Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.80 -0.08 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.88 | 52 Week High | $4.38 | |||
| Open | $48.97 | 52 Week Low | $1.88 | |||
| Day High | $49.94 | P/E | N/A | |||
| Day Low | $48.56 | EPS | $-1.12 | |||
| Volume | 95,663 | |||||
